Investing in healthcare properties in the UK, with all its rents government-backed, MedicX Fund shares now yield a base rate-busting 9.4%.
The closed-ended Guernsey-based fund, which raised £80m at IPO in November 2006 and has secured £100m of debt, owns 45 NHS doctors’ surgeries and primary health trusts around the UK, having added seven during the year to September. The net asset value of the properties at the year-end has been independently valued at 70.3p per share, down from 96.9p a year before, though the discounted cash flow net asset value has only fallen from 109.9p to 107.3p.
With properties unlikely to have changed hands much, the fall in value – which is equivalent to a 13% decline in the value of its sites – seems a rough estimation, but is anyway less than half the 30% fall of the benchmark of the IPD all-property index. Also, with tenants being reliable and stable – no voids on its books and rents being revised upwards every three years – it looks excessive.
The fund presently enjoys a rent-roll of £9.6m, up 4.6% over the year, and its cash yield of 5.8% compares well with the 30-year rate of 5% under which it secured its debt. The board intends to pay a final dividend of 2.6p, for an annual dividend of 5.2p.
Chairman Keith Maddin, who is one of the two investment advisers to the fund, does not plan to free up much, if any, of his current £24m cash resource, preferring to raise funds in the new year to take advantage of a claimed £85m pipeline.
AIM has numerous similarly sized funds of this ilk, tapping this solid niche. MedicX looks as good as any and, like many others, deserves a higher rating. Buy.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Market cap: £44.19m
PE Forecast: n/a
Share price: 55.5p
£7,277 That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.
Advertisement
Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.
M&A on AIM 2009 is a unique and wide-ranging examination of merger and acquisition activity on AIM over the past 12 months, with an analysis of all the acquisitions, disposals, takeovers and delistings on AIM, including
canvassing the opinions of some of the major M&A powerbrokers. To order click here.
Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.
Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.
The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today and benefit from a £10 discount!
This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.
Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Energy industry consultant KBC performed resiliently in recession-hit 2009 and entered 2010 with a robust order book.
Organic composting specialist TEG is pursuing long-term contracts after turning £1.6m of annual losses into £155,000 pre-tax profits in calendar 2009.
European Goldfields hopes to move from AIM to the Full List by the end of 2010 after securing a key permit in Romania.